Petros Pharmaceuticals, Inc. Deferred Tax Liabilities, Intangible Assets
Petros Pharmaceuticals, Inc. (PTPI) had Deferred Tax Liabilities, Intangible Assets of $565.29 thousand as of 2024-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities
us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets · last filed 2026-04-15
- 2024-12-31: Deferred Tax Liabilities, Intangible Assets $565.29K.
- 2023-12-31: Deferred Tax Liabilities, Intangible Assets $737.72K.
- 2022-12-31: Deferred Tax Liabilities, Intangible Assets $818.13K.
- 2021-12-31: Deferred Tax Liabilities, Intangible Assets $1.01M.
| Period end | Deferred Tax Liabilities, Intangible Assets |
|---|---|
| 2024-12-31 | $565.29K 10-K · filed 2026-04-15 |
| 2023-12-31 | $737.72K 10-K · filed 2025-03-31 |
| 2022-12-31 | $818.13K 10-K · filed 2024-04-01 |
| 2021-12-31 | $1.01M 10-K · filed 2023-03-31 |
| 2020-12-31 | $1.24M 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B |